When the coronavirus disease began to spread widely in the United States, ACCC members on the frontlines of the pandemic came together as a community to share their perspective and lessons learned by participating in ACCC webcasts, mini-podcasts, and blog posts. The educational resources included in this COVID-19 Resource Center represent the expertise, dedication, and generosity of ACCC members across the nation who have been deeply involved in caring for patients and establishing protocols for virus response since March 2020.
On January 7, 2021, U.S. Department of Health and Human Services (HHS) Secretary Alex Azar signed an extension of the COVID-19 public health emergency (PHE) designation until April 21, 2021. ACCC resources from the pandemic's acute phase and pre-vaccination phase are accessible to help cancer programs and practices that still face many pressing issues related to COVID-19.
COVID-19 Implications for Cancer Clinical Research and Quality Care
An expert panel of past ACCC Presidents will share their perspectives on changes to clinical research during the pandemic.
combatCOVID.hhs.gov provides important information and links to access the most current treatment guidelines and inpatient and outpatient clinical trials.
In the wake of COVID-19, seismic changes in the healthcare sector have pushed cancer care providers to continue to prove their resiliency and ability to quickly adapt to change. At the ACCC 47th Annual Meeting & Cancer Center Business Summit, March 1 – 5, hear real-world examples from institutions that have used the opportunity created by this pandemic to forge a new path forward.
View the complete agenda to explore additional sessions detailing the impact of COVID-19 on programs and practices across the U.S.
Reserve Your Seat Today
The ACCC Financial Advocacy Network developed the COVID-19 Financial Advocacy Resources hub to help cancer programs and practices to stay informed on rapidly changing updates to financial assistance programs and insurance coverage in response to the public health emergency. This resource will be reviewed and updated weekly.
Adoption & Expansion of Telehealth Solutions addresses the immediate and ongoing needs of cancer programs and practices that want to implement, integrate, and expand their telehealth services to optimize patient care during the current public health emergency and beyond. Through this effort, ACCC will help guide members of the multidisciplinary team in the areas of rapid response, policy rules and regulations, team-based telehealth delivery, technology needs, and actionable blueprints to build new telehealth solutions.
Teri Bedard, BA, RT(R)(T), CPC, Executive Director, Client & Corporate Resources, Revenue Cycle Coding Strategies, highlights what your cancer program needs to know by discussing the changes to telehealth services, supervision, provider-based designations, and coding for services. (July 10, 2020)
Deirdre Saulet, Advisory Board Company, and Amanda Henson, MSHA, MBA, FACHE, Baptist Health, share an overview of programs’ volumes in response to COVID-19, effective staffing strategies, tactics for supporting your care team, and how to prepare for potential future ‘waves’. (May 29, 2020)
Jenna VanGilder, MHA, RN, OCN, CENP, Edward Elmhurst Health, shares best practices in treating COVID+ patients with cancer, including the use of screening algorithms, approaches to patient and staff protection, communications planning. (May 1, 2020)
See what members are discussing in the COVID-19 Forum, exclusively for ACCC Members. (Requires Login)
Learn how genetic healthcare services have adapted to virtual care delivery, and what challenges face its widespread use after the COVID-19 pandemic is over.
Learn how the role of caregivers has changed during the pandemic, and how the cancer team can provide caregivers with guidance on taking care of patients with cancer.
We explore how patients are dealing with the "new normal,” and how oncology social workers, psychologists, and psychiatrists are working to help them through an unprecedented time.
Learn how some cancer programs are finding creative ways to engage patients and adapt screening programs during these difficult times.
Krista Nelson, ACCC President 2021-22, shares how Providence Cancer Institute has made staff resiliency and morale a priority during the COVID-19 pandemic.
Learn how music can help relieve coronavirus-related stress for both patients and cancer program staff.
We explore how the COVID-19 pandemic has affected patient access to oral oncolytics, and what cancer teams can do to help their patients.
Jeffrey Kendall, PsyD, LP, shares useful tips and resources for compassionate communication with patients during the COVID-19 pandemic.
Krista Nelson, ACCC President 2021-22, shares self-care resources for cancer team members during the COVID-19 outbreak and guides us through a brief mindfulness exercise.
The ASCO Survey on COVID-19 in Oncology Registry (ASCO Registry) is aimed to help ASCO examine the evidence on the effect of COVID-19 on patients with cancer. The ASCO Registry collects baseline and longitudinal data on patients with cancer and COVID-19 and plans to deliver periodic reports with key findings that can influence future care. The greater diversity and number of patients the Registry represents, the more we can learn from this unique experience in cancer care. Join the Registry.
ACCC launched a COVID-19 Resource Center in March 2020 to offer education and tools to community practitioners working directly on the frontlines.
Despite a century-long history and a substantial body of recent empirical evidence that attests to its clinical and economic effectiveness and improved access, telemedicine has yet to become a routine part of clinical practice for the majority of clinicians. If used appropriately, it can serve as an effective substitute for in-person care which does not require physical examination in nearly all facets of the medical care process, including prevention, diagnosis, treatment, monitoring, and follow-up.
SARS-CoV-2 and the resulting respiratory tract infection COVID-19 has upended our society and forcefully changed the way we care for patients. Since the emergence of the virus in early 2020, there have been questions surrounding the risk posed to patients with a cancer diagnosis and the safety of anticancer therapies.
The COVID-19 Pandemic is Increasing Cancer Deaths. Here’s What Needs to Be Done to Reverse It
The COVID-19 Pandemic Has Disrupted Cancer Trials
COVID-19 and the Rise in Cancer Mortality
Page last updated Feb 11, 2021